iShares Trust (IBB)
Perusahaan Manajemen · XNAS · Seri S000004350 · Lihat di SEC EDGAR ↗
$216,96
Per 19 Agu 2026
▲ +13,40 (+6,58%)
Perubahan 1 hari
$136,89 – $217,04
Rentang 52 minggu
+0,01%
Premi / Diskon
NAV per 18 Agu 2026
5 Feb. 2001
Awal
Arus bersih (30d): -$20.1M Diperkirakan dari pembuatan/penebusan saham beredar
- Aset bersih
- $10.1B
- Kepemilikan
- 252
- Per tanggal
- 17 Agu 2026
- Rasio biaya
- 0.44% (Moderat)
Di halaman ini
- Grafik harga Harga pasar dana dari waktu ke waktu, dengan lapisan teknis.
- Performa Pengembalian total, volatilitas, penurunan, dan metrik risiko lainnya.
- Arus dana Uang yang masuk dan keluar dari dana setiap bulan, dari pengajuan N-PORT.
- Kepemilikan Setiap posisi yang saat ini dipegang oleh dana, dengan bobotnya.
- Rincian sektor Bagaimana kepemilikan dana terbagi di berbagai sektor pasar.
- Perubahan terbaru Posisi yang paling baru ditambahkan, dikurangi, atau keluar dari dana.
- Pemilik institusional Institusi 13F yang melaporkan kepemilikan ETF ini.
- Dana serupa Dana lain dengan kepemilikan yang tumpang tindih atau ukuran yang sebanding.
IBB Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Performa per 19 Agu 2026
| Periode | Imbal hasil harga | Imbal hasil total |
|---|---|---|
| 1M | ▲ +12,28% | — |
| 3M | ▲ +29,77% | — |
| 6M | ▲ +21,73% | — |
| YTD | ▲ +26,25% | — |
| 1Y | ▲ +54,52% | — |
| 3Y | — | — |
| 5Y | — | — |
| Maks sejak 27 Feb. 2024 | ▲ +51,23% | — |
- Volatilitas 1T
- 20,88%
- Volatilitas 3Y
- —
- Penurunan Maksimum 3Y
- —
- Beta 3Y
- 0,42
- Sharpe 1Y*
- 2,19
Pengembalian total ditampilkan setelah riwayat dividen untuk dana ini dikumpulkan — pengembalian harga saja akan menduplikasinya secara menyesatkan. Pengembalian tidak dibandingkan dengan indeks. * Rasio Sharpe dihitung dengan suku bunga bebas risiko 0%.
Aliran dana (dilaporkan SEC)
- Bulan lalu (Mar 2026)
- -$332.0M
- Kuartal berakhir Mar 2026
- -$208.5M
- 12 bulan terakhir
- +$630.9M
Apr 2025 – Mar 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Komposisi Penuh 252 saham
| Penerbit | Ticker | Bobot % | Nilai pasar | Saham | CUSIP | Unit/saham | Tipe | Mata Uang |
|---|---|---|---|---|---|---|---|---|
| PRIME MEDICINE | PRME | 0,02 | ≈$2.1M | 700.164 | 74168J101 | 0.01403 | EQUITY | USD |
| ANAVEX LIFE SCIENCES CORP | AVXL | 0,02 | ≈$2.1M | 660.171 | 032797300 | 0.01323 | EQUITY | USD |
| MYRIAD GENETICS | MYGN | 0,02 | ≈$1.9M | 651.944 | 62855J104 | 0.01307 | EQUITY | USD |
| STANDARD BIOTOOLS | LAB | 0,02 | ≈$1.8M | 2.767.978 | 34385P108 | 0.05547 | EQUITY | USD |
| UPSTREAM BIO | UPB | 0,02 | ≈$1.8M | 267.654 | 91678A107 | 0.005364 | EQUITY | USD |
| EMERGENT BIOSOLUTIONS | EBS | 0,02 | ≈$1.7M | 359.008 | 29089Q105 | 0.007195 | EQUITY | USD |
| FULCRUM THERAPEUTICS | FULC | 0,02 | ≈$1.6M | 415.960 | 359616109 | 0.008336 | EQUITY | USD |
| ARCTURUS THERAPEUTICS HOLDINGS INC | ARCT | 0,02 | ≈$1.6M | 192.010 | 03969T109 | 0.003848 | EQUITY | USD |
| LARIMAR THERAPEUTICS | LRMR | 0,02 | ≈$1.6M | 387.201 | 517125100 | 0.00776 | EQUITY | USD |
| FOGHORN THERAPEUTICS | FHTX | 0,02 | ≈$1.6M | 231.774 | 344174107 | 0.004645 | EQUITY | USD |
| LINEAGE CELL THERAPEUTICS INC | LCTX | 0,01 | ≈$1.5M | 1.381.503 | 53566P109 | 0.02769 | EQUITY | USD |
| KEROS THERAPEUTICS | KROS | 0,01 | ≈$1.4M | 134.266 | 492327101 | 0.002688 | EQUITY | USD |
| PEPGEN | PEPG | 0,01 | ≈$1.3M | 468.686 | 713317105 | 0.009393 | EQUITY | USD |
| VOYAGER THERAPEUTICS | VYGR | 0,01 | ≈$1.2M | 364.057 | 92915B106 | 0.007296 | EQUITY | USD |
| NOVABRIDGE BIOSCIENCES ADR | NBP | 0,01 | ≈$1.2M | 617.998 | 44975P103 | 0.01238 | EQUITY | USD |
| PYXIS ONCOLOGY INC | PYXS | 0,01 | ≈$1.2M | 391.536 | 747324101 | 0.007846 | EQUITY | USD |
| SIONNA THERAPEUTICS | SION | 0,01 | ≈$1.2M | 196.099 | 829401108 | 0.00393 | EQUITY | USD |
| AC IMMUNE SA | ACIU | 0,01 | ≈$1.1M | 452.347 | CH0329023102 | 0.009065 | EQUITY | USD |
| ENTRADA THERAPEUTICS | TRDA | 0,01 | ≈$1.1M | 157.674 | 29384C108 | 0.00316 | EQUITY | USD |
| BICYCLE THERAPEUTICS ADR PLC | BCYC | 0,01 | ≈$1.1M | 275.861 | 088786108 | 0.005528 | EQUITY | USD |
| TENAYA THERAPEUTICS | TNYA | 0,01 | ≈$1.1M | 1.557.625 | 87990A106 | 0.03121 | EQUITY | USD |
| USD CASH | USD | 0,01 | ≈$1.1M | 1.091.866 | X2f5743ed867 | 0.02188 | CASH | USD |
| HUMACYTE INC | HUMA | 0,01 | ≈$1.0M | 1.814.420 | 44486Q103 | 0.03636 | EQUITY | USD |
| CARIBOU BIOSCIENCES | CRBU | 0,01 | ≈$1.0M | 656.892 | 142038108 | 0.01316 | EQUITY | USD |
| LENZ THERAPEUTICS | LENZ | 0,01 | ≈$957K | 201.699 | 52635N103 | 0.004042 | EQUITY | USD |
| CODEXIS | CDXS | 0,01 | ≈$927K | 620.362 | 192005106 | 0.01243 | EQUITY | USD |
| NEUMORA THERAPEUTICS INC | NMRA | 0,01 | ≈$927K | 568.034 | 640979100 | 0.01138 | EQUITY | USD |
| QUANTUM SI INC CLASS A | QSI | 0,01 | ≈$907K | 1.251.742 | 74765K105 | 0.02509 | EQUITY | USD |
| LYELL IMMUNOPHARMA | LYEL | 0,01 | ≈$886K | 56.522 | 55083R203 | 0.001133 | EQUITY | USD |
| QUANTERIX | QTRX | 0,01 | ≈$776K | 293.037 | 74766Q101 | 0.005872 | EQUITY | USD |
| BLACK DIAMOND THERAPEUTICS INC | BDTX | 0,01 | ≈$745K | 362.725 | 09203E105 | 0.007269 | EQUITY | USD |
| ADC THERAPEUTICS SA | ADCT | 0,01 | ≈$715K | 699.042 | CH0499880968 | 0.01401 | EQUITY | USD |
| CELLECTIS ADR REPRESENTING SA | CLLS | 0,01 | ≈$695K | 233.133 | 15117K103 | 0.004672 | EQUITY | USD |
| AARDVARK THERAPEUTICS | AARD | 0,01 | ≈$564K | 93.123 | 002942100 | 0.001864 | EQUITY | USD |
| ALPHA TEKNOVA | TKNO | 0,01 | ≈$544K | 80.648 | 02080L102 | 0.001616 | EQUITY | USD |
| GOSSAMER BIO | GOSS | 0,00 | ≈$473K | 3.319.663 | 38341P102 | 0.06653 | EQUITY | USD |
| JYONG BIOTECH LTD | MENS | 0,00 | ≈$433K | 214.454 | KYG831161065 | 0.004298 | EQUITY | USD |
| AKERO THERAPEUTICS CVR | AKE | 0,00 | ≈$332K | 515.954 | 009CVR044 | 0.01034 | EQUITY | USD |
| IMMUTEP ADS REPRESENTING LTD | IMMP | 0,00 | ≈$302K | 766.478 | 45257L108 | 0.01536 | EQUITY | USD |
| CASH COLLATERAL USD SGAFT | SGAFT | 0,00 | ≈$151K | 156.000 | Xe4f63973721 | 0.003126 | COLLATERAL | USD |
| CHINOOK THERAPEUTICS INC | ADRO | 0,00 | ≈$50K | 320.962 | 169CVR016 | 0.006432 | EQUITY | USD |
| ARCELLX INC CVR | 0,00 | ≈$20K | 335.814 | 039CVR014 | 0.00673 | EQUITY | USD | |
| AKOUOS CVRS Prvt | 0,00 | — | 157.087 | 009CVR036 | 0.003148 | EQUITY | USD | |
| BLK CSH FND TREASURY SL AGENCY | XTSLA | 0,00 | — | 0 | 066922477 | 0 | CASH | USD |
| CARGO THERAPEUTICS INC | CRGX | 0,00 | — | 198.104 | 141CVR019 | 0.00397 | EQUITY | USD |
| CARTESIAN THERAPEUTICS INC | 0,00 | — | 7.496 | 816212112 | 0.0001502 | EQUITY | USD | |
| E-MINI HEALTH CARE SECTOR SEP 26 | IXCU6 | 0,00 | — | 9 | Xb8103e27ed0 | 0.0000001804 | FUTURE | USD |
| FUSION PHARMACEUTICALS INC CVR | 0,00 | — | 1.880 | 361CVR012 | 0.00003768 | EQUITY | USD | |
| OMNIAB INC $12.50 VESTING Prvt | 0,00 | — | 46.839 | 68218J202 | 0.0009387 | EQUITY | USD | |
| OMNIAB INC $15.00 VESTING Prvt | 0,00 | — | 46.839 | 68218J301 | 0.0009387 | EQUITY | USD |
Nilai pasar diestimasi dari bobot setiap kepemilikan dan aset bersih reksa dana. Bobot dan jumlah saham dilaporkan oleh reksa dana.
Halaman 5
dari 6
Rincian sektor
Healthcare
99,4%
Lainnya/Tidak terpetakan
0,6%
Perubahan Harian (30h)
| Tanggal | Tipe | Ticker | Perubahan |
|---|---|---|---|
| 18 Agu 2026 | Meningkat |
ABCL — ABCELLERA BIOLOGICS
00288U106
|
Unit/saham: 0.03495 → 0.03499 (0,1%) |
| 18 Agu 2026 | Meningkat |
ABSI — ABSCI CORP
00091E109
|
Unit/saham: 0.01995 → 0.01997 (0,1%) |
| 18 Agu 2026 | Meningkat |
ABUS — ARBUTUS BIOPHARMA CORP
03879J100
|
Unit/saham: 0.02357 → 0.02359 (0,1%) |
| 18 Agu 2026 | Meningkat |
ABVX — ABIVAX AMERICAN DEPOSITARY SHARES
00370M103
|
Unit/saham: 0.009638 → 0.009647 (0,1%) |
| 18 Agu 2026 | Meningkat |
ACAD — ACADIA PHARMACEUTICALS
004225108
|
Unit/saham: 0.02508 → 0.02511 (0,1%) |
| 18 Agu 2026 | Meningkat |
ACIU — AC IMMUNE SA
CH0329023102
|
Unit/saham: 0.009056 → 0.009065 (0,1%) |
| 18 Agu 2026 | Meningkat |
ACRS — ACLARIS THERAPEUTICS
00461U105
|
Unit/saham: 0.01628 → 0.0163 (0,1%) |
| 18 Agu 2026 | Meningkat |
ADCT — ADC THERAPEUTICS SA
CH0499880968
|
Unit/saham: 0.01399 → 0.01401 (0,1%) |
| 18 Agu 2026 | Meningkat |
ADMA — ADMA BIOLOGICS
000899104
|
Unit/saham: 0.03345 → 0.03348 (0,1%) |
| 18 Agu 2026 | Meningkat |
ADPT — ADAPTIVE BIOTECHNOLOGIES
00650F109
|
Unit/saham: 0.02299 → 0.02302 (0,1%) |
| 18 Agu 2026 | Meningkat |
AGIO — AGIOS PHARMACEUTICALS
00847X104
|
Unit/saham: 0.008274 → 0.008282 (0,1%) |
| 18 Agu 2026 | Meningkat |
ALKS — ALKERMES
IE00B56GVS15
|
Unit/saham: 0.02422 → 0.02425 (0,1%) |
| 18 Agu 2026 | Meningkat |
ALLO — ALLOGENE THERAPEUTICS
019770106
|
Unit/saham: 0.03773 → 0.03777 (0,1%) |
| 18 Agu 2026 | Meningkat |
ALMS — ALUMIS
022307102
|
Unit/saham: 0.01243 → 0.01244 (0,1%) |
| 18 Agu 2026 | Meningkat |
ALNY — ALNYLAM PHARMACEUTICALS
02043Q107
|
Unit/saham: 0.01976 → 0.01978 (0,1%) |
| 18 Agu 2026 | Meningkat |
ALT — ALTIMMUNE INC
02155H200
|
Unit/saham: 0.02711 → 0.02713 (0,1%) |
| 18 Agu 2026 | Meningkat |
ALVO — ALVOTECH SA
LU2458332611
|
Unit/saham: 0.02087 → 0.02089 (0,1%) |
| 18 Agu 2026 | Meningkat |
AMGN — AMGEN INC
031162100
|
Unit/saham: 0.04121 → 0.04125 (0,1%) |
| 18 Agu 2026 | Meningkat |
AMLX — AMYLYX PHARMACEUTICALS
03237H101
|
Unit/saham: 0.01378 → 0.01379 (0,1%) |
| 18 Agu 2026 | Meningkat |
ANNX — ANNEXON
03589W102
|
Unit/saham: 0.02143 → 0.02146 (0,1%) |
| 18 Agu 2026 | Meningkat |
ANRO — ALTO NEUROSCIENCE INC
02157Q109
|
Unit/saham: 0.005231 → 0.005237 (0,1%) |
| 18 Agu 2026 | Meningkat |
APGE — APOGEE THERAPEUTICS
03770N101
|
Unit/saham: 0.008465 → 0.008474 (0,1%) |
| 18 Agu 2026 | Meningkat |
ARCT — ARCTURUS THERAPEUTICS HOLDINGS INC
03969T109
|
Unit/saham: 0.003844 → 0.003848 (0,1%) |
| 18 Agu 2026 | Meningkat |
ARGX — ARGENX SE ADR
04016X101
|
Unit/saham: 0.007723 → 0.007731 (0,1%) |
| 18 Agu 2026 | Meningkat |
ARQT — ARCUTIS BIOTHERAPEUTICS
03969K108
|
Unit/saham: 0.01644 → 0.01646 (0,1%) |
| 18 Agu 2026 | Meningkat |
ARVN — ARVINAS INC
04335A105
|
Unit/saham: 0.008025 → 0.008033 (0,1%) |
| 18 Agu 2026 | Meningkat |
ARWR — ARROWHEAD PHARMACEUTICALS
04280A100
|
Unit/saham: 0.01967 → 0.01969 (0,1%) |
| 18 Agu 2026 | Meningkat |
ASND — ASCENDIS PHARMA
DK0060615755
|
Unit/saham: 0.009191 → 0.0092 (0,1%) |
| 18 Agu 2026 | Meningkat |
ATAI — ATAIBECKLEY INC
04650F101
|
Unit/saham: 0.04375 → 0.04379 (0,1%) |
| 18 Agu 2026 | Meningkat |
AUPH — AURINIA PHARMACEUTICALS
05156V102
|
Unit/saham: 0.0169 → 0.01692 (0,1%) |
| 18 Agu 2026 | Meningkat |
AURA — AURA BIOSCIENCES
05153U107
|
Unit/saham: 0.009539 → 0.009549 (0,1%) |
| 18 Agu 2026 | Meningkat |
AUTL — AUTOLUS THERAPEUTICS ADR PLC
05280R100
|
Unit/saham: 0.02989 → 0.02992 (0,1%) |
| 18 Agu 2026 | Meningkat |
AVBP — ARRIVENT BIOPHARMA
04272N102
|
Unit/saham: 0.004879 → 0.004884 (0,1%) |
| 18 Agu 2026 | Meningkat |
AVIR — ATEA PHARMACEUTICALS
04683R106
|
Unit/saham: 0.009559 → 0.009568 (0,1%) |
| 18 Agu 2026 | Meningkat |
AVXL — ANAVEX LIFE SCIENCES CORP
032797300
|
Unit/saham: 0.01322 → 0.01323 (0,1%) |
| 18 Agu 2026 | Meningkat |
AXSM — AXSOME THERAPEUTICS
05464T104
|
Unit/saham: 0.006401 → 0.006408 (0,1%) |
| 18 Agu 2026 | Meningkat |
BBIO — BRIDGEBIO PHARMA
10806X102
|
Unit/saham: 0.02513 → 0.02516 (0,1%) |
| 18 Agu 2026 | Meningkat |
BBOT — BRIDGEBIO ONCOLOGY THERAPEUTICS IN
107924102
|
Unit/saham: 0.006402 → 0.006408 (0,1%) |
| 18 Agu 2026 | Meningkat |
BCAX — BICARA THERAPEUTICS INC
055477103
|
Unit/saham: 0.005611 → 0.005616 (0,1%) |
| 18 Agu 2026 | Meningkat |
BCRX — BIOCRYST PHARMACEUTICALS
09058V103
|
Unit/saham: 0.03199 → 0.03202 (0,1%) |
| 18 Agu 2026 | Meningkat |
BCYC — BICYCLE THERAPEUTICS ADR PLC
088786108
|
Unit/saham: 0.005523 → 0.005528 (0,1%) |
| 18 Agu 2026 | Meningkat |
BDTX — BLACK DIAMOND THERAPEUTICS INC
09203E105
|
Unit/saham: 0.007262 → 0.007269 (0,1%) |
| 18 Agu 2026 | Meningkat |
BEAM — BEAM THERAPEUTICS
07373V105
|
Unit/saham: 0.01397 → 0.01398 (0,1%) |
| 18 Agu 2026 | Meningkat |
BHVN — BIOHAVEN
VGG1110E1079
|
Unit/saham: 0.01863 → 0.01864 (0,1%) |
| 18 Agu 2026 | Meningkat |
BIIB — BIOGEN
09062X103
|
Unit/saham: 0.02176 → 0.02178 (0,1%) |
| 18 Agu 2026 | Meningkat |
BIOA — BIOAGE LABS
09077V100
|
Unit/saham: 0.004673 → 0.004677 (0,1%) |
| 18 Agu 2026 | Meningkat |
BMRN — BIOMARIN PHARMACEUTICAL
09061G101
|
Unit/saham: 0.02829 → 0.02832 (0,1%) |
| 18 Agu 2026 | Meningkat |
BNTX — BIONTECH SE ADR
09075V102
|
Unit/saham: 0.01359 → 0.01361 (0,1%) |
| 18 Agu 2026 | Meningkat |
BRKR — BRUKER
116794108
|
Unit/saham: 0.01651 → 0.01653 (0,1%) |
| 18 Agu 2026 | Meningkat |
CABA — CABALETTA BIO
12674W109
|
Unit/saham: 0.02107 → 0.02109 (0,1%) |
| 18 Agu 2026 | Meningkat |
CADL — CANDEL THERAPEUTICS INC
137404109
|
Unit/saham: 0.008588 → 0.008596 (0,1%) |
| 18 Agu 2026 | Meningkat |
CAI — CARIS LIFE SCIENCES
142152107
|
Unit/saham: 0.01818 → 0.01819 (0,1%) |
| 18 Agu 2026 | Meningkat |
CATX — PERSPECTIVE THERAPEUTICS INC
46489V302
|
Unit/saham: 0.01331 → 0.01332 (0,1%) |
| 18 Agu 2026 | Meningkat |
CCCC — C4 THERAPEUTICS
12529R107
|
Unit/saham: 0.0148 → 0.01481 (0,1%) |
| 18 Agu 2026 | Meningkat |
CDNA — CAREDX
14167L103
|
Unit/saham: 0.006942 → 0.006949 (0,1%) |
| 18 Agu 2026 | Meningkat |
CDXS — CODEXIS
192005106
|
Unit/saham: 0.01242 → 0.01243 (0,1%) |
| 18 Agu 2026 | Meningkat |
CGEM — CULLINAN THERAPEUTICS
230031106
|
Unit/saham: 0.006678 → 0.006685 (0,1%) |
| 18 Agu 2026 | Meningkat |
CGON — CG ONCOLOGY
156944100
|
Unit/saham: 0.008557 → 0.008565 (0,1%) |
| 18 Agu 2026 | Meningkat |
CLLS — CELLECTIS ADR REPRESENTING SA
15117K103
|
Unit/saham: 0.004667 → 0.004672 (0,1%) |
| 18 Agu 2026 | Meningkat |
CMPS — COMPASS PATHWAYS ADR PLC
20451W101
|
Unit/saham: 0.01615 → 0.01617 (0,1%) |
| 18 Agu 2026 | Meningkat |
COGT — COGENT BIOSCIENCES
19240Q201
|
Unit/saham: 0.02185 → 0.02187 (0,1%) |
| 18 Agu 2026 | Meningkat |
CRBU — CARIBOU BIOSCIENCES
142038108
|
Unit/saham: 0.01315 → 0.01316 (0,1%) |
| 18 Agu 2026 | Meningkat |
CRL — CHARLES RIVER LABORATORIES INTERNA
159864107
|
Unit/saham: 0.007075 → 0.007082 (0,1%) |
| 18 Agu 2026 | Meningkat |
CRNX — CRINETICS PHARMACEUTICALS
22663K107
|
Unit/saham: 0.01454 → 0.01456 (0,1%) |
| 18 Agu 2026 | Meningkat |
CRSP — CRISPR THERAPEUTICS AG
CH0334081137
|
Unit/saham: 0.01333 → 0.01334 (0,1%) |
| 18 Agu 2026 | Meningkat |
CRVS — CORVUS PHARMACEUTICALS
221015100
|
Unit/saham: 0.009455 → 0.009464 (0,1%) |
| 18 Agu 2026 | Meningkat |
CSTL — CASTLE BIOSCIENCES
14843C105
|
Unit/saham: 0.004434 → 0.004439 (0,1%) |
| 18 Agu 2026 | Meningkat |
CTKB — CYTEK BIOSCIENCES
23285D109
|
Unit/saham: 0.01743 → 0.01745 (0,1%) |
| 18 Agu 2026 | Meningkat |
CTMX — CYTOMX THERAPEUTICS
23284F105
|
Unit/saham: 0.02466 → 0.02468 (0,1%) |
| 18 Agu 2026 | Meningkat |
CTNM — CONTINEUM THERAPEUTICS INC CLASS A
21217B100
|
Unit/saham: 0.004292 → 0.004297 (0,1%) |
| 18 Agu 2026 | Meningkat |
CYTK — CYTOKINETICS
23282W605
|
Unit/saham: 0.01771 → 0.01773 (0,1%) |
| 18 Agu 2026 | Meningkat |
DFTX — DEFINIUM THERAPEUTICS INC
24477V105
|
Unit/saham: 0.01893 → 0.01895 (0,1%) |
| 18 Agu 2026 | Meningkat |
DNA — GINKGO BIOWORKS HOLDINGS CLASS A
37611X209
|
Unit/saham: 0.007453 → 0.00746 (0,1%) |
| 18 Agu 2026 | Meningkat |
DNLI — DENALI THERAPEUTICS
24823R105
|
Unit/saham: 0.02214 → 0.02217 (0,1%) |
| 18 Agu 2026 | Meningkat |
DSGN — DESIGN THERAPEUTICS
25056L103
|
Unit/saham: 0.005559 → 0.005565 (0,1%) |
| 18 Agu 2026 | Meningkat |
DYN — DYNE THERAPEUTICS
26818M108
|
Unit/saham: 0.02226 → 0.02228 (0,1%) |
| 18 Agu 2026 | Meningkat |
EBS — EMERGENT BIOSOLUTIONS
29089Q105
|
Unit/saham: 0.007187 → 0.007195 (0,1%) |
| 18 Agu 2026 | Meningkat |
EDIT — EDITAS MEDICINE
28106W103
|
Unit/saham: 0.02095 → 0.02097 (0,1%) |
| 18 Agu 2026 | Meningkat |
ELVN — ENLIVEN THERAPEUTICS
29337E102
|
Unit/saham: 0.008257 → 0.008265 (0,1%) |
| 18 Agu 2026 | Meningkat |
ENTA — ENANTA PHARMACEUTICALS INC
29251M106
|
Unit/saham: 0.004074 → 0.004078 (0,1%) |
| 18 Agu 2026 | Meningkat |
ERAS — ERASCA
29479A108
|
Unit/saham: 0.03097 → 0.031 (0,1%) |
| 18 Agu 2026 | Meningkat |
EWTX — EDGEWISE THERAPEUTICS
28036F105
|
Unit/saham: 0.01168 → 0.01169 (0,1%) |
| 18 Agu 2026 | Meningkat |
EXEL — EXELIXIS INC
30161Q104
|
Unit/saham: 0.03621 → 0.03624 (0,1%) |
| 18 Agu 2026 | Meningkat |
FDMT — 4D MOLECULAR THERAPEUTICS INC
35104E100
|
Unit/saham: 0.006883 → 0.00689 (0,1%) |
| 18 Agu 2026 | Meningkat |
FHTX — FOGHORN THERAPEUTICS
344174107
|
Unit/saham: 0.00464 → 0.004645 (0,1%) |
| 18 Agu 2026 | Meningkat |
FLGT — FULGENT GENETICS INC
359664109
|
Unit/saham: 0.002697 → 0.0027 (0,1%) |
| 18 Agu 2026 | Meningkat |
FTRE — FORTREA HOLDINGS INC
34965K107
|
Unit/saham: 0.014 → 0.01402 (0,1%) |
| 18 Agu 2026 | Meningkat |
FULC — FULCRUM THERAPEUTICS
359616109
|
Unit/saham: 0.008328 → 0.008336 (0,1%) |
| 18 Agu 2026 | Meningkat |
GERN — GERON
374163103
|
Unit/saham: 0.09393 → 0.09402 (0,1%) |
| 18 Agu 2026 | Meningkat |
GHRS — GH RESEARCH PLC
IE000GID8VI0
|
Unit/saham: 0.007236 → 0.007244 (0,1%) |
| 18 Agu 2026 | Meningkat |
GILD — GILEAD SCIENCES INC
375558103
|
Unit/saham: 0.1032 → 0.1033 (0,1%) |
| 18 Agu 2026 | Meningkat |
GLUE — MONTE ROSA THERAPEUTICS
61225M102
|
Unit/saham: 0.008759 → 0.008768 (0,1%) |
| 18 Agu 2026 | Meningkat |
GMAB — GENMAB SPONSORED ADR
372303206
|
Unit/saham: 0.07764 → 0.07772 (0,1%) |
| 18 Agu 2026 | Meningkat |
GOSS — GOSSAMER BIO
38341P102
|
Unit/saham: 0.06646 → 0.06653 (0,1%) |
| 18 Agu 2026 | Meningkat |
GPCR — STRUCTURE THERAPEUTICS ADR
86366E106
|
Unit/saham: 0.008707 → 0.008716 (0,1%) |
| 18 Agu 2026 | Meningkat |
GRAL — GRAIL INC
384747101
|
Unit/saham: 0.005904 → 0.00591 (0,1%) |
| 18 Agu 2026 | Meningkat |
GRFS — GRIFOLS ADR REPRESENTING ONE NON-V
398438408
|
Unit/saham: 0.03277 → 0.0328 (0,1%) |
| 18 Agu 2026 | Meningkat |
HALO — HALOZYME THERAPEUTICS
40637H109
|
Unit/saham: 0.01745 → 0.01747 (0,1%) |
| 18 Agu 2026 | Meningkat |
HUMA — HUMACYTE INC
44486Q103
|
Unit/saham: 0.03632 → 0.03636 (0,1%) |
| 18 Agu 2026 | Meningkat |
IBRX — IMMUNITYBIO INC
45256X103
|
Unit/saham: 0.05602 → 0.05607 (0,1%) |
| 18 Agu 2026 | Meningkat |
IDYA — IDEAYA BIOSCIENCES
45166A102
|
Unit/saham: 0.01237 → 0.01238 (0,1%) |
| 18 Agu 2026 | Meningkat |
ILMN — ILLUMINA INC
452327109
|
Unit/saham: 0.02243 → 0.02245 (0,1%) |
| 18 Agu 2026 | Meningkat |
IMCR — IMMUNOCORE HOLDINGS ADR PLC
45258D105
|
Unit/saham: 0.006315 → 0.006322 (0,1%) |
| 18 Agu 2026 | Meningkat |
IMMP — IMMUTEP ADS REPRESENTING LTD
45257L108
|
Unit/saham: 0.01534 → 0.01536 (0,1%) |
| 18 Agu 2026 | Meningkat |
IMRX — IMMUNEERING CLASS A
45254E107
|
Unit/saham: 0.008499 → 0.008508 (0,1%) |
| 18 Agu 2026 | Meningkat |
IMVT — IMMUNOVANT
45258J102
|
Unit/saham: 0.01205 → 0.01206 (0,1%) |
| 18 Agu 2026 | Meningkat |
INCY — INCYTE CORP
45337C102
|
Unit/saham: 0.02942 → 0.02945 (0,1%) |
| 18 Agu 2026 | Meningkat |
INSM — INSMED INC
457669307
|
Unit/saham: 0.03191 → 0.03194 (0,1%) |
| 18 Agu 2026 | Meningkat |
IONS — IONIS PHARMACEUTICALS
462222100
|
Unit/saham: 0.02409 → 0.02411 (0,1%) |
| 18 Agu 2026 | Meningkat |
IOVA — IOVANCE BIOTHERAPEUTICS INC
462260100
|
Unit/saham: 0.05775 → 0.05781 (0,1%) |
| 18 Agu 2026 | Meningkat |
IRON — DISC MEDICINE
254604101
|
Unit/saham: 0.004105 → 0.004109 (0,1%) |
| 18 Agu 2026 | Meningkat |
IRWD — IRONWOOD PHARMA CLASS A
46333X108
|
Unit/saham: 0.02336 → 0.02338 (0,1%) |
| 18 Agu 2026 | Meningkat |
JANX — JANUX THERAPEUTICS
47103J105
|
Unit/saham: 0.008563 → 0.008572 (0,1%) |
| 18 Agu 2026 | Meningkat |
KOD — KODIAK SCIENCES
50015M109
|
Unit/saham: 0.008588 → 0.008596 (0,1%) |
| 18 Agu 2026 | Meningkat |
KRYS — KRYSTAL BIOTECH
501147102
|
Unit/saham: 0.003824 → 0.003828 (0,1%) |
| 18 Agu 2026 | Meningkat |
KURA — KURA ONCOLOGY
50127T109
|
Unit/saham: 0.01285 → 0.01286 (0,1%) |
| 18 Agu 2026 | Meningkat |
KYMR — KYMERA THERAPEUTICS
501575104
|
Unit/saham: 0.01057 → 0.01058 (0,1%) |
| 18 Agu 2026 | Meningkat |
KYTX — KYVERNA THERAPEUTICS
501976104
|
Unit/saham: 0.005569 → 0.005574 (0,1%) |
| 18 Agu 2026 | Meningkat |
LAB — STANDARD BIOTOOLS
34385P108
|
Unit/saham: 0.05541 → 0.05547 (0,1%) |
| 18 Agu 2026 | Meningkat |
LCTX — LINEAGE CELL THERAPEUTICS INC
53566P109
|
Unit/saham: 0.02766 → 0.02769 (0,1%) |
| 18 Agu 2026 | Meningkat |
LEGN — LEGEND BIOTECH ADR REP
52490G102
|
Unit/saham: 0.02201 → 0.02203 (0,1%) |
| 18 Agu 2026 | Meningkat |
LENZ — LENZ THERAPEUTICS
52635N103
|
Unit/saham: 0.004038 → 0.004042 (0,1%) |
| 18 Agu 2026 | Meningkat |
LKFT — LAKEFRONT BIOTHERAPEUTICS ADR NV
36315X101
|
Unit/saham: 0.006184 → 0.00619 (0,1%) |
| 18 Agu 2026 | Meningkat |
LRMR — LARIMAR THERAPEUTICS
517125100
|
Unit/saham: 0.007752 → 0.00776 (0,1%) |
| 18 Agu 2026 | Meningkat |
LXEO — LEXEO THERAPEUTICS
52886X107
|
Unit/saham: 0.009101 → 0.009111 (0,1%) |
| 18 Agu 2026 | Meningkat |
LYEL — LYELL IMMUNOPHARMA
55083R203
|
Unit/saham: 0.001132 → 0.001133 (0,1%) |
| 18 Agu 2026 | Meningkat |
MAZE — MAZE THERAPEUTICS
578784100
|
Unit/saham: 0.005148 → 0.005153 (0,1%) |
| 18 Agu 2026 | Meningkat |
MBX — MBX BIOSCIENCES
55287L101
|
Unit/saham: 0.004384 → 0.004388 (0,1%) |
| 18 Agu 2026 | Meningkat |
MDGL — MADRIGAL PHARMACEUTICALS
558868105
|
Unit/saham: 0.003225 → 0.003228 (0,1%) |
| 18 Agu 2026 | Meningkat |
MEDP — MEDPACE HOLDINGS
58506Q109
|
Unit/saham: 0.00342 → 0.003423 (0,1%) |
| 18 Agu 2026 | Meningkat |
MENS — JYONG BIOTECH LTD
KYG831161065
|
Unit/saham: 0.004293 → 0.004298 (0,1%) |
| 18 Agu 2026 | Meningkat |
MESO — MESOBLAST ADR REPRESENTING
590717401
|
Unit/saham: 0.01047 → 0.01048 (0,1%) |
| 18 Agu 2026 | Meningkat |
MGTX — MEIRAGTX HOLDINGS PLC
KYG596651029
|
Unit/saham: 0.0105 → 0.01051 (0,1%) |
| 18 Agu 2026 | Meningkat |
MIRM — MIRUM PHARMACEUTICALS
604749101
|
Unit/saham: 0.007365 → 0.007373 (0,1%) |
| 18 Agu 2026 | Meningkat |
MLYS — MINERALYS THERAPEUTICS
603170101
|
Unit/saham: 0.009022 → 0.009031 (0,1%) |
| 18 Agu 2026 | Meningkat |
MNKD — MANNKIND
56400P706
|
Unit/saham: 0.04393 → 0.04397 (0,1%) |
| 18 Agu 2026 | Meningkat |
MRNA — MODERNA INC
60770K107
|
Unit/saham: 0.05401 → 0.05406 (0,1%) |
| 18 Agu 2026 | Meningkat |
MRVI — MARAVAI LIFESCIENCES HOLDINGS INC
56600D107
|
Unit/saham: 0.01577 → 0.01579 (0,1%) |
| 18 Agu 2026 | Meningkat |
MYGN — MYRIAD GENETICS
62855J104
|
Unit/saham: 0.01305 → 0.01307 (0,1%) |
| 18 Agu 2026 | Meningkat |
NAMS — NEWAMSTERDAM PHARMA
NL00150012L7
|
Unit/saham: 0.01194 → 0.01196 (0,1%) |
| 18 Agu 2026 | Meningkat |
NBIX — NEUROCRINE BIOSCIENCES
64125C109
|
Unit/saham: 0.01468 → 0.0147 (0,1%) |
| 18 Agu 2026 | Meningkat |
NBP — NOVABRIDGE BIOSCIENCES ADR
44975P103
|
Unit/saham: 0.01237 → 0.01238 (0,1%) |
| 18 Agu 2026 | Meningkat |
NGNE — NEUROGENE INC
64135M105
|
Unit/saham: 0.002355 → 0.002358 (0,1%) |
| 18 Agu 2026 | Meningkat |
NMRA — NEUMORA THERAPEUTICS INC
640979100
|
Unit/saham: 0.01137 → 0.01138 (0,1%) |
| 18 Agu 2026 | Meningkat |
NRIX — NURIX THERAPEUTICS INC
67080M103
|
Unit/saham: 0.01455 → 0.01456 (0,1%) |
| 18 Agu 2026 | Meningkat |
NTLA — INTELLIA THERAPEUTICS
45826J105
|
Unit/saham: 0.01964 → 0.01966 (0,1%) |
| 18 Agu 2026 | Meningkat |
NTRA — NATERA
632307104
|
Unit/saham: 0.0203 → 0.02032 (0,1%) |
| 18 Agu 2026 | Meningkat |
NUVB — NUVATION BIO CLASS A
67080N101
|
Unit/saham: 0.0368 → 0.03684 (0,1%) |
| 18 Agu 2026 | Meningkat |
NVAX — NOVAVAX
670002401
|
Unit/saham: 0.02324 → 0.02326 (0,1%) |
| 18 Agu 2026 | Meningkat |
NVCR — NOVOCURE
JE00BYSS4X48
|
Unit/saham: 0.0155 → 0.01552 (0,1%) |
| 18 Agu 2026 | Meningkat |
OABI — OMNIAB INC
68218J103
|
Unit/saham: 0.01732 → 0.01734 (0,1%) |
| 18 Agu 2026 | Meningkat |
OLMA — OLEMA PHARMACEUTICALS
68062P106
|
Unit/saham: 0.01043 → 0.01044 (0,1%) |
| 18 Agu 2026 | Meningkat |
ONC — BEONE MEDICINES AG
07725L102
|
Unit/saham: 0.01183 → 0.01185 (0,1%) |
| 18 Agu 2026 | Meningkat |
OPK — OPKO HEALTH
68375N103
|
Unit/saham: 0.05568 → 0.05573 (0,1%) |
| 18 Agu 2026 | Meningkat |
ORIC — ORIC PHARMACEUTICALS
68622P109
|
Unit/saham: 0.009186 → 0.009195 (0,1%) |
| 18 Agu 2026 | Meningkat |
ORKA — ORUKA THERAPEUTICS INC
687604108
|
Unit/saham: 0.007536 → 0.007544 (0,1%) |
| 18 Agu 2026 | Meningkat |
PACB — PACIFIC BIOSCIENCES OF CALIFORNIA
69404D108
|
Unit/saham: 0.04303 → 0.04307 (0,1%) |
| 18 Agu 2026 | Meningkat |
PCVX — VAXCYTE
92243G108
|
Unit/saham: 0.02098 → 0.021 (0,1%) |
| 18 Agu 2026 | Meningkat |
PEPG — PEPGEN
713317105
|
Unit/saham: 0.009383 → 0.009393 (0,1%) |
| 18 Agu 2026 | Meningkat |
PGEN — PRECIGEN
74017N105
|
Unit/saham: 0.02337 → 0.02339 (0,1%) |
| 18 Agu 2026 | Meningkat |
PHAT — PHATHOM PHARMACEUTICALS
71722W107
|
Unit/saham: 0.008398 → 0.008406 (0,1%) |
| 18 Agu 2026 | Meningkat |
PHVS — PHARVARIS N V
NL00150005Y4
|
Unit/saham: 0.004337 → 0.004341 (0,1%) |
| 18 Agu 2026 | Meningkat |
PRAX — PRAXIS PRECISION MEDICINES
74006W207
|
Unit/saham: 0.00388 → 0.003884 (0,1%) |
| 18 Agu 2026 | Meningkat |
PRME — PRIME MEDICINE
74168J101
|
Unit/saham: 0.01402 → 0.01403 (0,1%) |
| 18 Agu 2026 | Meningkat |
PRTA — PROTHENA PLC
IE00B91XRN20
|
Unit/saham: 0.006895 → 0.006902 (0,1%) |
| 18 Agu 2026 | Meningkat |
PSNL — PERSONALIS
71535D106
|
Unit/saham: 0.009265 → 0.009275 (0,1%) |
| 18 Agu 2026 | Meningkat |
PTCT — PTC THERAPEUTICS
69366J200
|
Unit/saham: 0.0119 → 0.01192 (0,1%) |
| 18 Agu 2026 | Meningkat |
PTGX — PROTAGONIST THERAPEUTICS
74366E102
|
Unit/saham: 0.009068 → 0.009077 (0,1%) |
| 18 Agu 2026 | Meningkat |
PYXS — PYXIS ONCOLOGY INC
747324101
|
Unit/saham: 0.007839 → 0.007846 (0,1%) |
| 18 Agu 2026 | Meningkat |
QSI — QUANTUM SI INC CLASS A
74765K105
|
Unit/saham: 0.02506 → 0.02509 (0,1%) |
| 18 Agu 2026 | Meningkat |
QTRX — QUANTERIX
74766Q101
|
Unit/saham: 0.005867 → 0.005872 (0,1%) |
| 18 Agu 2026 | Meningkat |
QURE — UNIQURE
NL0010696654
|
Unit/saham: 0.008422 → 0.008431 (0,1%) |
| 18 Agu 2026 | Meningkat |
RAPP — RAPPORT THERAPEUTICS
75383L102
|
Unit/saham: 0.004244 → 0.004248 (0,1%) |
| 18 Agu 2026 | Meningkat |
RARE — ULTRAGENYX PHARMACEUTICAL
90400D108
|
Unit/saham: 0.01335 → 0.01337 (0,1%) |
| 18 Agu 2026 | Meningkat |
RCKT — ROCKET PHARMACEUTICALS
77313F106
|
Unit/saham: 0.01528 → 0.0153 (0,1%) |
| 18 Agu 2026 | Meningkat |
RCUS — ARCUS BIOSCIENCES
03969F109
|
Unit/saham: 0.01241 → 0.01243 (0,1%) |
| 18 Agu 2026 | Meningkat |
REGN — REGENERON PHARMACEUTICALS
75886F107
|
Unit/saham: 0.015 → 0.01501 (0,1%) |
| 18 Agu 2026 | Meningkat |
REPL — REPLIMUNE GROUP
76029N106
|
Unit/saham: 0.01145 → 0.01146 (0,1%) |
| 18 Agu 2026 | Meningkat |
RGEN — REPLIGEN
759916109
|
Unit/saham: 0.00793 → 0.007938 (0,1%) |
| 18 Agu 2026 | Meningkat |
RGNX — REGENXBIO
75901B107
|
Unit/saham: 0.008741 → 0.00875 (0,1%) |
| 18 Agu 2026 | Meningkat |
RIGL — RIGEL PHARMACEUTICALS
766559702
|
Unit/saham: 0.002684 → 0.002687 (0,1%) |
| 18 Agu 2026 | Meningkat |
RLAY — RELAY THERAPEUTICS
75943R102
|
Unit/saham: 0.0244 → 0.02442 (0,1%) |
| 18 Agu 2026 | Meningkat |
ROIV — ROIVANT SCIENCES LTD
BMG762791017
|
Unit/saham: 0.07675 → 0.07682 (0,1%) |
| 18 Agu 2026 | Meningkat |
RVMD — REVOLUTION MEDICINES
76155X100
|
Unit/saham: 0.0283 → 0.02833 (0,1%) |
| 18 Agu 2026 | Meningkat |
RXRX — RECURSION PHARMACEUTICALS CLASS A
75629V104
|
Unit/saham: 0.06982 → 0.06989 (0,1%) |
| 18 Agu 2026 | Meningkat |
RYTM — RHYTHM PHARMACEUTICALS
76243J105
|
Unit/saham: 0.009861 → 0.009871 (0,1%) |
| 18 Agu 2026 | Meningkat |
SANA — SANA BIOTECHNOLOGY
799566104
|
Unit/saham: 0.02671 → 0.02673 (0,1%) |
| 18 Agu 2026 | Meningkat |
SEPN — SEPTERNA
81734D104
|
Unit/saham: 0.00409 → 0.004094 (0,1%) |
| 18 Agu 2026 | Meningkat |
SGMT — SAGIMET BIOSCIENCES SERIES A
786700104
|
Unit/saham: 0.008647 → 0.008655 (0,1%) |
| 18 Agu 2026 | Meningkat |
SION — SIONNA THERAPEUTICS
829401108
|
Unit/saham: 0.003926 → 0.00393 (0,1%) |
| 18 Agu 2026 | Meningkat |
SLDB — SOLID BIOSCIENCES INC
83422E204
|
Unit/saham: 0.01175 → 0.01176 (0,1%) |
| 18 Agu 2026 | Meningkat |
SLN — SILENCE THERAPEUTICS ADR REPRESENT
82686Q101
|
Unit/saham: 0.003886 → 0.00389 (0,1%) |
| 18 Agu 2026 | Meningkat |
SMMT — SUMMIT THERAPEUTICS
86627T108
|
Unit/saham: 0.02 → 0.02002 (0,1%) |
| 18 Agu 2026 | Meningkat |
SNDX — SYNDAX PHARMACEUTICALS
87164F105
|
Unit/saham: 0.01196 → 0.01197 (0,1%) |
| 18 Agu 2026 | Meningkat |
SPRY — ARS PHARMACEUTICALS INC
82835W108
|
Unit/saham: 0.009249 → 0.009258 (0,1%) |
| 18 Agu 2026 | Meningkat |
SRPT — SAREPTA THERAPEUTICS
803607100
|
Unit/saham: 0.01504 → 0.01505 (0,1%) |
| 18 Agu 2026 | Meningkat |
SRRK — SCHOLAR ROCK HOLDING
80706P103
|
Unit/saham: 0.01431 → 0.01432 (0,1%) |
| 18 Agu 2026 | Meningkat |
STOK — STOKE THERAPEUTICS
86150R107
|
Unit/saham: 0.007321 → 0.007329 (0,1%) |
| 18 Agu 2026 | Meningkat |
STVN — STEVANATO GROUP
IT0005452658
|
Unit/saham: 0.007366 → 0.007373 (0,1%) |
| 18 Agu 2026 | Meningkat |
SVRA — SAVARA
805111101
|
Unit/saham: 0.01574 → 0.01576 (0,1%) |
Menampilkan 200 terbaru dari 5226 perubahan
Pemilik institusional (13F) 1.036 pengaju
Institusi yang melaporkan kepemilikan ETF ini dalam Formulir SEC 13F triwulanan mereka. Hanya posisi long; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Institusi | Nilai | % dari 13F yang dilacak | Saham | Tipe | Per tanggal |
|---|---|---|---|---|---|
| BNP PARIBAS FINANCIAL MARKETS | $421.829.818 | 9,50% | 2.217.939 | Saham | 30 Juni 2026 |
| TWO SIGMA INVESTMENTS, LP | $302.042.070 | 6,80% | 1.588.107 | Saham | 30 Juni 2026 |
| GOLDMAN SACHS GROUP INC | $221.873.575 | 5,00% | 1.166.589 | Saham | 30 Juni 2026 |
| ENVESTNET ASSET MANAGEMENT INC | $213.518.446 | 4,81% | 1.122.659 | Saham | 30 Juni 2026 |
| RAYMOND JAMES FINANCIAL INC | $169.085.529 | 3,81% | 889.035 | Saham | 30 Juni 2026 |
| PEAK6 LLC | $157.876.719 | 3,56% | 830.100 | Opsi beli | 30 Juni 2026 |
| LPL Financial LLC | $150.135.091 | 3,38% | 789.395 | Saham | 30 Juni 2026 |
| COMMERCE BANK | $149.648.339 | 3,37% | 786.836 | Saham | 30 Juni 2026 |
| UBS Group AG | $141.457.236 | 3,19% | 743.768 | Saham | 30 Juni 2026 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $138.077.940 | 3,11% | 726.000 | Saham | 30 Juni 2026 |
| TRUIST FINANCIAL CORP | $127.368.703 | 2,87% | 669.692 | Saham | 30 Juni 2026 |
| WestEnd Advisors, LLC | $124.744.693 | 2,81% | 655.852 | Saham | 30 Juni 2026 |
| BANK OF AMERICA CORP /DE/ | $100.538.047 | 2,26% | 528.619 | Saham | 30 Juni 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $79.613.534 | 1,79% | 418.600 | Opsi jual | 30 Juni 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $68.886.818 | 1,55% | 362.200 | Opsi beli | 30 Juni 2026 |
| WELLS FARGO & COMPANY/MN | $66.566.500 | 1,50% | 350.000 | Saham | 30 Juni 2026 |
| Jefferies Financial Group Inc. | $57.495.733 | 1,29% | 302.306 | Saham | 30 Juni 2026 |
| VICTORY CAPITAL MANAGEMENT INC | $44.563.427 | 1,00% | 234.310 | Saham | 30 Juni 2026 |
| BARCLAYS PLC | $38.297.609 | 0,86% | 201.365 | Saham | 30 Juni 2026 |
| PNC Financial Services Group, Inc. | $38.000.913 | 0,86% | 199.805 | Saham | 30 Juni 2026 |
| CITADEL ADVISORS LLC | $31.096.065 | 0,70% | 163.500 | Opsi beli | 30 Juni 2026 |
| STIFEL FINANCIAL CORP | $26.437.159 | 0,60% | 138.996 | Saham | 30 Juni 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | $26.214.727 | 0,59% | 137.834 | Saham | 30 Juni 2026 |
| AMERIPRISE FINANCIAL INC | $24.642.402 | 0,55% | 128.884 | Saham | 30 Juni 2026 |
| Focus Partners Wealth | $24.013.121 | 0,54% | 126.258 | Saham | 30 Juni 2026 |
| ALBION FINANCIAL GROUP /UT | $22.753.461 | 0,51% | 119.635 | Saham | 30 Juni 2026 |
| Generali Investments CEE, investicni spolecnost, a.s. | $22.083.912 | 0,50% | 116.115 | Saham | 30 Juni 2026 |
| Cetera Investment Advisers | $22.024.704 | 0,50% | 115.804 | Saham | 30 Juni 2026 |
| JANE STREET GROUP, LLC | $20.730.710 | 0,47% | 109.000 | Opsi jual | 30 Juni 2026 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $19.368.569 | 0,44% | 101.838 | Saham | 30 Juni 2026 |
| Itau Unibanco Holding S.A. | $18.805.226 | 0,42% | 98.876 | Saham | 30 Juni 2026 |
| INVESTMENT HOUSE LLC | $18.394.226 | 0,41% | 96.715 | Saham | 30 Juni 2026 |
| ExodusPoint Capital Management, LP | $18.265.467 | 0,41% | 96.038 | Saham | 30 Juni 2026 |
| Erste Asset Management GmbH | $17.342.761 | 0,39% | 102.330 | Saham | 30 Juni 2026 |
| CITADEL ADVISORS LLC | $16.869.853 | 0,38% | 88.700 | Opsi jual | 30 Juni 2026 |
| MML INVESTORS SERVICES, LLC | $16.284.678 | 0,37% | 85.623 | Saham | 30 Juni 2026 |
| ASSETMARK, INC | $16.221.132 | 0,37% | 85.289 | Saham | 30 Juni 2026 |
| OSAIC HOLDINGS, INC. | $16.095.532 | 0,36% | 84.570 | Saham | 30 Juni 2026 |
| JANE STREET GROUP, LLC | $15.614.599 | 0,35% | 82.100 | Opsi beli | 30 Juni 2026 |
| MAI Capital Management | $15.522.282 | 0,35% | 81.615 | Saham | 30 Juni 2026 |
| FACTORY MUTUAL INSURANCE CO | $13.503.490 | 0,30% | 71.000 | Saham | 30 Juni 2026 |
| D. E. Shaw & Co., Inc. | $13.117.594 | 0,30% | 68.971 | Saham | 30 Juni 2026 |
| Bronte Capital Management Pty Ltd. | $12.515.833 | 0,28% | 65.807 | Saham | 30 Juni 2026 |
| CUMBERLAND ADVISORS INC | $12.175.583 | 0,27% | 64.018 | Saham | 30 Juni 2026 |
| NTV Asset Management LLC | $12.169.323 | 0,27% | 63.985 | Saham | 30 Juni 2026 |
| Beacon Pointe Advisors, LLC | $12.038.493 | 0,27% | 63.297 | Saham | 30 Juni 2026 |
| Tradition Wealth Management, LLC | $11.826.840 | 0,27% | 62.184 | Saham | 30 Juni 2026 |
| FOLGER NOLAN FLEMING DOUGLAS CAPITAL MANAGEMENT, INC | $11.607.345 | 0,26% | 61.030 | Saham | 30 Juni 2026 |
| Horizon Wealth Management, LLC | $11.465.582 | 0,26% | 60.285 | Saham | 30 Juni 2026 |
| Apella Capital, LLC | $11.404.083 | 0,26% | 57.530 | Saham | 30 Juni 2026 |
| Corient Private Wealth LP | $10.770.613 | 0,24% | 56.629 | Saham | 30 Juni 2026 |
| Pictet Asset Management Holding SA | $10.428.961 | 0,23% | 54.950 | Saham | 30 Juni 2026 |
| Parker Investment Management, LLC | $10.423.041 | 0,23% | 54.803 | Saham | 30 Juni 2026 |
| BROWN ADVISORY INC | $10.213.796 | 0,23% | 53.703 | Saham | 30 Juni 2026 |
| CAPITAL FUND MANAGEMENT S.A. | $10.107.647 | 0,23% | 53.145 | Saham | 30 Juni 2026 |
| Reyes Financial Architecture, Inc. | $10.058.198 | 0,23% | 52.885 | Saham | 30 Juni 2026 |
| Waverly Advisors, LLC | $9.987.833 | 0,22% | 52.515 | Saham | 30 Juni 2026 |
| MILLENNIUM MANAGEMENT LLC | $9.884.935 | 0,22% | 51.974 | Saham | 30 Juni 2026 |
| Sanctuary Advisors, LLC | $9.795.378 | 0,22% | 51.503 | Saham | 30 Juni 2026 |
| Humankind Investments LLC | $9.509.500 | 0,21% | 50.000 | Saham | 30 Juni 2026 |
| IFP Advisors, Inc | $9.507.218 | 0,21% | 49.988 | Saham | 30 Juni 2026 |
| Steward Partners Investment Advisory, LLC | $9.190.076 | 0,21% | 48.321 | Saham | 30 Juni 2026 |
| Qube Research & Technologies Ltd | $8.991.803 | 0,20% | 47.278 | Saham | 30 Juni 2026 |
| Kestra Advisory Services, LLC | $8.975.993 | 0,20% | 47.195 | Saham | 30 Juni 2026 |
| Henshaw Capital LLC | $8.938.930 | 0,20% | 47.000 | Saham | 30 Juni 2026 |
| L & S Advisors Inc | $8.757.108 | 0,20% | 46.044 | Saham | 30 Juni 2026 |
| HighTower Advisors, LLC | $8.749.554 | 0,20% | 46.004 | Saham | 30 Juni 2026 |
| DAVENPORT & Co LLC | $8.615.552 | 0,19% | 45.300 | Saham | 30 Juni 2026 |
| WOLVERINE TRADING, LLC | $8.288.262 | 0,19% | 58.200 | Opsi jual | 30 Sep. 2025 |
| FORBES J M & CO LLP | $8.248.730 | 0,19% | 43.371 | Saham | 30 Juni 2026 |
| DAFNA Capital Management LLC | $8.101.143 | 0,18% | 42.595 | Saham | 30 Juni 2026 |
| TOTH FINANCIAL ADVISORY CORP | $8.037.702 | 0,18% | 42.261 | Saham | 30 Juni 2026 |
| SP Asset Management LLC | $7.838.297 | 0,18% | 41.213 | Saham | 30 Juni 2026 |
| Summit Financial, LLC | $7.552.142 | 0,17% | 39.708 | Saham | 30 Juni 2026 |
| MMBG INVESTMENT ADVISORS CO. | $7.158.181 | 0,16% | 37.637 | Saham | 30 Juni 2026 |
| EQUITABLE TRUST CO | $6.731.775 | 0,15% | 35.395 | Saham | 30 Juni 2026 |
| BEARING POINT CAPITAL, LLC | $6.714.468 | 0,15% | 35.304 | Saham | 30 Juni 2026 |
| Michelson Medical Research Foundation, Inc. | $6.674.718 | 0,15% | 35.095 | Saham | 30 Juni 2026 |
| Caption Management, LLC | $6.637.631 | 0,15% | 34.900 | Opsi jual | 30 Juni 2026 |
| J. Goldman & Co LP | $6.637.631 | 0,15% | 34.900 | Opsi jual | 30 Juni 2026 |
| Addison Capital Co | $6.542.048 | 0,15% | 34.397 | Saham | 30 Juni 2026 |
| Williams Jones Wealth Management, LLC. | $6.450.674 | 0,15% | 33.917 | Saham | 30 Juni 2026 |
| JONES FINANCIAL COMPANIES LLLP | $6.351.704 | 0,14% | 33.901 | Saham | 30 Juni 2026 |
| WOLVERINE TRADING, LLC | $6.166.353 | 0,14% | 43.300 | Opsi beli | 30 Sep. 2025 |
| Equitable Holdings, Inc. | $5.996.315 | 0,14% | 31.528 | Saham | 30 Juni 2026 |
| Colonial Trust Advisors | $5.970.421 | 0,13% | 31.392 | Saham | 30 Juni 2026 |
| McCollum Christoferson Group LLC | $5.881.436 | 0,13% | 30.924 | Saham | 30 Juni 2026 |
| Aristides Capital LLC | $5.782.917 | 0,13% | 30.406 | Saham | 30 Juni 2026 |
| Y-Intercept (Hong Kong) Ltd | $5.758.953 | 0,13% | 30.280 | Saham | 30 Juni 2026 |
| Mariner, LLC | $5.618.618 | 0,13% | 29.542 | Saham | 30 Juni 2026 |
| Volterra Technologies LP | $5.571.996 | 0,13% | 29.297 | Saham | 30 Juni 2026 |
| Caption Management, LLC | $5.553.548 | 0,13% | 29.200 | Opsi beli | 30 Juni 2026 |
| SOUTHERN CAPITAL ADVISORS, LLC | $5.517.058 | 0,12% | 29.008 | Saham | 30 Juni 2026 |
| Howard Capital Management Group, LLC | $5.494.011 | 0,12% | 28.887 | Saham | 30 Juni 2026 |
| CMH Wealth Management LLC | $5.484.700 | 0,12% | 28.838 | Saham | 30 Juni 2026 |
| Crescent Grove Advisors, LLC | $5.443.300 | 0,12% | 28.620 | Saham | 30 Juni 2026 |
| Ashton Thomas Private Wealth, LLC | $5.335.590 | 0,12% | 28.054 | Saham | 30 Juni 2026 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $5.334.446 | 0,12% | 29.848 | Saham | 30 Juni 2026 |
| Gladstone Institutional Advisory LLC | $5.245.758 | 0,12% | 27.582 | Saham | 30 Juni 2026 |
| FIFTH THIRD BANCORP | $5.221.717 | 0,12% | 27.456 | Saham | 30 Juni 2026 |
Dana sejawat
Lainnya dari penerbit ini
Serupa berdasarkan ukuran
| Dana | AUM |
|---|---|
| PAAA PGIM ETF Trust | $10.2B |
| EWZ iShares, Inc. | $10.2B |
| IGF iShares Trust | $10.5B |
| VPU VANGUARD WORLD FUND | $10.6B |
| JIRE J.P. Morgan Exchange-Traded Fun… | $10.6B |
| DFCF Dimensional ETF Trust | $10.1B |
| SCHH SCHWAB STRATEGIC TRUST | $10.0B |
| BUFR First Trust Exchange-Traded Fun… | $9.6B |
| FNDE SCHWAB STRATEGIC TRUST | $9.6B |
| PRF Invesco Exchange-Traded Fund Tr… | $9.5B |